Data from Catalent’s preclinical studies evaluating certepetide as a SMARTag® ADC payload showed both improved tumor selective penetration and efficacy BASKING RIDGE, N.J., Nov. 04, 2025 (GLOBE ...
For Chaikesh Chouragade, an artificial intelligence research scientist at ZZAZZ AI Solutions, this question has guided a career at the intersection of economics and technology.
How AI, robotics, and precision medicine are transforming cancer care—bridging hope, technology, and humanity in the ongoing ...
IFF (NYSE: IFF) reported financial results for the third quarter ended September 30, 2025.
An NIH-funded study found deep learning tools could forecast next-day relapse risk with high accuracy, giving clinicians time to intervene.
The surge in AI and digital infrastructure is making data centers the fastest-growing source of new electricity demand in ...
The global community is facing a number of urgent challenges, such as emerging diseases, epidemics, antimicrobial resistance, ...
Thanks to AI, data science tasks that once demanded specialized skills can now be performed faster, more accurately and at a ...
Could you defend your customer feedback metrics on an earnings call with the same confidence you defend your revenue ...
CTX-10726 demonstrated potent, simultaneous inhibition of tumor angiogenesis and PD-1-mediated immune suppression, and eliminated tumors in multiple preclinical studies.In vivo, CTX-10726 outperformed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results